NEW YORK ( TheStreet) -- Bio-Reference Labs (Nasdaq: BRLI) hit a new 52-week high Thursday as it is currently trading at $24.49, above its previous 52-week high of $24.48 with 234,207 shares traded as of 4 p.m. ET. Average volume has been 223,400 shares over the past 30 days. Bio-Reference has a market cap of $637 million and is part of the health care sector and health services industry. Shares are up 28.1% year to date as of the close of trading on Wednesday. Bio-Reference Laboratories, Inc. provides clinical laboratory testing services for the detection, diagnosis, evaluation, monitoring, and treatment of diseases primarily in the greater New York metropolitan area. The company has a P/E ratio of 17.3, equal to the average health services industry P/E ratio and below the S&P 500 P/E ratio of 17.7.
- Sign up for TheStreet's FREE Dividend and Income Investor Newsletter